Cytora Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.cytora.com
Clinical Trials
2
Active:2
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Study for Treatment of Chronic Diabetic Foot Ulcers With the Investigational Allogeneic Cell Therapy Product, hOMSC200
Phase 1
Active, not recruiting
- Conditions
- Diabetic Foot UlcerDiabetic Foot Ulcer NeuropathicDiabetic Foot
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Cytora Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT06003530
- Locations
- 🇮🇱
Shaare Zedek Medical Center, Jerusalem, Israel
Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)
Phase 1
Active, not recruiting
- Conditions
- Multiple System AtrophyMSA - Multiple System Atrophy
- Interventions
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Cytora Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT05698017
- Locations
- 🇮🇱
Tel-Aviv Sourasky Medical Center (Ichilov), Tel Aviv, Israel
News
No news found